Tag Archives: FDA
Using Social Media to Sell Prescription Drugs
Jean-Christophe Bélisle-Pipon and Stanislav Birko consider how direct-to-consumer marketing of prescription drugs using social media might be prevented by amending Canada’s Food and Drug Regulations.
Lupron: Déjà Vu All Over Again
Alice Dreger raises concerns about a pervasive pattern of non-evidence based assumptions driving practices in pediatric endocrinology.
“Female Viagra”: Is this little pink pill worth it?
Katy Fulfer addresses concerns about the approval of “female Viagra”
FDA Ethicist’s Undisclosed Conflicts of Interest in Prenatal Dex Case
Newly available documents show conflicts of interest for the FDA ethicist who investigated a fetal drug experiment. Alice Dreger and Ellen K. Feder explain.
Impact Ethics 